跳至主要内容
临床试验/NCT02888262
NCT02888262进行中(未招募)不适用

The Bipolar Illness Onset Study (the BIO Study)

Mental Health Services in the Capital Region, Denmark1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
700
试验地点
1
主要终点
Composite blood based biomarker

研究概览

简要总结

This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder

详细描述

The study will include 300 patients with newly diagnosed/first episode bipolar disorder, 200 healthy siblings or child family members and 100 healthy individuals without a family history of affective disorder. All individuals will be investigated with repeated blood tests, Smartphone recordings, neuropsychological tests and brain imaging during a five to ten year study period.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Newly diagnosed/first episode bipolar patients,
  • •First-generation relatives (siblings and children aged 15 to 40 years) to the recruited newly diagnosed/first episode bipolar patients.
  • •Age- and gender matched sample of healthy individuals without a first-generation family history of effective disorders

排除标准

  • •Significant physical disorders
  • •Schizophrenia or related disorders

结局指标

主要结局

Composite blood based biomarker

时间窗: 5 years

次要结局

  • Composite smartphone based biomarker including self reported and smartphone generated data(5 years)
  • Composite neurocognitive marker including "Cold" and "Hot" cognition.(5 years)

研究者

发起方
Mental Health Services in the Capital Region, Denmark
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lars Vedel Kessing

Professor, MD, DMSc.

Mental Health Services in the Capital Region, Denmark

研究点 (1)

Loading locations...

相似试验